Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-022695

Director sold 15,295 shares at $9.12 ($139,490)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vance Terry Director 2023-12-13 Sale −15,295 $9.12 $139,490 5,800 D: show line 1 in the form
Open-market sales · 15,295 sh · avg $9.12 · $139,490
Loading xslF345X05/form4.xml…